Synthesis of new 4-[2-(alkylamino)ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino)ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors

References

• Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004; 64: 159–204
   PubMed Web of Science ®Google Scholar
• Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol Rev 1996; 60: 575–608
   PubMedGoogle Scholar
• Ling V. Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997; 40: S3–S8
   PubMed Web of Science ®Google Scholar
• Marshall NJ, Piddock LJ. Antibacterial efflux systems. Microbiologia 1997; 13: 285–300
   PubMedGoogle Scholar
• Kaatz GW, Seo SM. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1995; 39: 2650–2655
   PubMed Web of Science ®Google Scholar
• Kaatz GW, Seo SM, Ruble CA. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37: 1086–1094
   PubMed Web of Science ®Google Scholar
• Kaatz GW, Seo SM, Ruble CA. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J Infect Dis 1991; 163: 1080–1086
   PubMed Web of Science ®Google Scholar
• Hsieh PC, Siegel SA, Rogers B, Davis D, Lewis K. Bacteria lacking a multidrug pump: A sensitive tool for drug discovery. Proc Natl Acad Sci U S A 1998; 95: 6602–6606
   PubMed Web of Science ®Google Scholar
• Neyfakh AA, Borsch CM, Kaatz GW. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob Agents Chemother 1993; 37: 128–129
   PubMed Web of Science ®Google Scholar
• Aeschlimann JR, Dresser LD, Kaatz GW, Rybak MJ. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 335–340
   PubMed Web of Science ®Google Scholar
• Gibbons S, Oluwatuyi M, Kaatz GW. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 2003; 51: 13–17
   PubMed Web of Science ®Google Scholar
• Kaatz GW, Moudgal VV, Seo SM, Hansen JB, Kristiansen JE. Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Int J Antimicrob Agents 2003; 22: 254–261
   PubMed Web of Science ®Google Scholar
• Kaatz GW, Moudgal VV, Seo SM, Kristiansen JE. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 719–726
   PubMed Web of Science ®Google Scholar
• Kaatz GW, Seo SM, Foster TJ. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration. Antimicrob Agents Chemother 1999; 43: 2222–2224
   PubMed Web of Science ®Google Scholar
• Kaatz GW, Seo SM. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 1997; 41: 2733–2737
   PubMed Web of Science ®Google Scholar
• Markham PN, Westhaus E, Klyachko K, Johnson ME, Neyfakh AA. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 2404–2408
   PubMed Web of Science ®Google Scholar
• Yu JL, Grinius L, Hooper DC. NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J Bacteriol 2002; 184: 1370–1377
   PubMed Web of Science ®Google Scholar
• Wei P, Kaatz GW, Kerns RJ. Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps. Bioorg Med Chem Lett 2004; 14: 3093–3097
   PubMed Web of Science ®Google Scholar
• Gallo S, Atifi S, Mahamoud A, Santelli-Rouvier C, Wolfart K. Synthesis of aza mono, bi and tricyclic compounds. Evaluation of their anti MDR activity. Eur J Med Chem 2003; 38: 19–26
   PubMed Web of Science ®Google Scholar
• Samosorn S, Bremner JB, Ball A, Lewis K. Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors. Bioorg Med Chem 2006; 14: 857–865
   PubMed Web of Science ®Google Scholar
• Chevalier J, Atifi S, Eyraud A, Mahamoud A, Barbe J. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. J Med Chem 2001; 44: 4023–4026
   PubMed Web of Science ®Google Scholar
• Kayirere MG, Mahamoud A, Soyfer JC, Cremieux A, Barbe J. Synthesis and antibacterial activity of new 4-alkoxy, 4-aminoalkyl, and 4-alkylthioquinoline derivatives. Eur J Med Chem 1998; 33: 55–63
   Web of Science ®Google Scholar
• Guillon J, Pfeiffer B, Renard P, Manchez D, Kervran A, Rault S. Synthesis of new pyrrolo[1,2-a]quinoxalines potential non peptide glucagon receptor antagonist. Eur J Med Chem 1998; 33: 293–308
   Web of Science ®Google Scholar
• Guillon J, Boulouard M, Lisowski V, Stiebing S, Lelong V. Synthesis of new 2-(aminomethyl)-4-phenylpyrrolo[1,2-a]-quinoxalines and their preliminary in vivo central dopamine antagonist activity evaluation in mice. J Pharm Pharmacol 2000; 52: 1369–1375
   PubMed Web of Science ®Google Scholar
• Guillon J, Grellier P, Labaied M, Sonnet P, Leger JM, Deprez-Poulain R, Forfar-Bares I, Dallemagne P, Lemaitre N, Pehourcq F, Rochette J, Sergheraert C, Jarry C. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines. J Med Chem 2004; 47: 1997–2009
   PubMed Web of Science ®Google Scholar
• Nagarajan K, Ranga RV, Venkateswarlu A. Condensed heterocycles: Pyrrolo[1,2-a]quinoxaline derivatives. Indian J Chem 1972; 10: 344–350
   Google Scholar
• Ba BB, Arpin C, Vidaillac C, Chausse A, Saux MC, Quentin C. Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrob Agents Chemother 2006; 50: 1931–1936
   PubMed Web of Science ®Google Scholar
• Members of the SFM Antibiogram Committee, report 2003. Int J Antimicrob Agents 2003; 21: 364–391
   PubMed Web of Science ®Google Scholar
• Itoh T, Mase T. Direct synthesis of hetero-biaryl compounds containing an unprotected NH2 group via Suzuki-Miyaura reaction. Tetrahedron Lett 2005; 46: 3573–3577
   Web of Science ®Google Scholar
• Clauson-Kaas N, Tyle Z. Preparation of cis and trans 2,5-dimethoxy-2-(acetamidomethyl)-2,5-dihydrofuran, of cis and trans 2,5-dimethoxy-2-(acetamidomethyl)-tetrahydrofuran and 1-phenyl-2-(acetamidomethyl)pyrrole. Acta Chem Scand 1952; 6: 667–670
   Google Scholar
• Borah H, Prajapati D, Sandlu JS. Bismuth (III) chloride-sodium borohydride: A new and efficient system for the selective reduction of nitroarenes and azomethines. Chem Res Symp 1994; 6: 228–229
   Google Scholar
• Ren PD, Pan SF, Dong TW, Wu SH. The novel reduction systems: NaBH4-SbCl3 or NaBH4-BiCl3 for conversion of nitroarenes to primary amines. Synth Commun 1995; 25: 3703–3799
   Web of Science ®Google Scholar
• Kunz K, Scholz U, Ganzer D. Renaissance of Ullmann and Goldberg reactions - progress in copper catalysed C-N-, C-O and C-S coupling. Synlett 2003; 15: 2428–2439
   Google Scholar
• Kwong FY, Buchwald SL. A general, efficient, and inexpensive catalyst system for the coupling of aryl iodides and thiols. Organic Lett 2002; 4: 3517–3520
   PubMed Web of Science ®Google Scholar
• Bates CG, Gujadhur RK, Venkataraman D. A general method for the formation of aryl-sulfur bonds using copper(I) catalysts. Organic Lett 2002; 4: 2803–2806
   PubMed Web of Science ®Google Scholar
• Migita T, Shimizu T, Asami J, Shiobara J, Kato Y. The palladium catalysed nucleophilic substitution of aryl halides by thiolate anions. Bull Chem Soc Jpn 1980; 53: 1385–1389
   Web of Science ®Google Scholar
• Kondo T, Mitsudo TA. Metal-catalysed carbon-sulfur formation. Chem Rev 2000; 100: 3205–3220
   PubMed Web of Science ®Google Scholar
• Rault S, Lancelot JC, Prunier H, Robba M, Renard P. Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines. J Med Chem 1996; 39: 2068–2080
   PubMed Web of Science ®Google Scholar
• Takenouchi T, Tabata F, Iwata Y, Hanzawa H, Sugawara M. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother 1996; 40: 1835–1842
   PubMed Web of Science ®Google Scholar
• Sharma P, Rane N, Pandey P. Synthesis and evaluation of antimicrobial activity of novel hydrazino and N-benzylidinehydrazino-substituted 4,8-dihydro-1H,3H-pyrimido[4,5-d]pyrimidin-2,7-dithiones. Arch Pharm Chem Life Sci 2006; 339: 572–578
   PubMed Web of Science ®Google Scholar